Recent Quarter Total Invested
$27.07 M
Recent Quarter Institutional Ownership Percentage
31.94%
Total Invested of Last Quarter
$26.93 M
Ownership Percentage of Last Quarter
27.93%
Eton Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 2.40 M | $7.88 M | -2.08% | 9.30% |
| VANGUARD GROUP INC | 08/13/2024 | 1.03 M | $3.38 M | 0.00% | 3.99% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/20/2024 | 940,733 | $3.10 M | 100.00% | 3.65% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 07/17/2024 | 585,400 | $1.93 M | 1.99% | 2.27% |
| ACUITAS INVESTMENTS, LLC | 08/05/2024 | 579,960 | $1.91 M | 0.00% | 2.25% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 08/14/2024 | 300,000 | $987,000 | 0.00% | 1.16% |
| BLACKROCK INC. | 08/13/2024 | 282,389 | $929,060 | -0.20% | 1.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 253,362 | $833,561 | 0.00% | 0.98% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 253,197 | $833,018 | 27.13% | 0.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 240,331 | $790,884 | 2.63% | 0.93% |
| ARISTIDES CAPITAL LLC | 08/23/2024 | 200,000 | $658,000 | 100.00% | 0.78% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 134,288 | $441,807 | -32.59% | 0.52% |
| THOMPSON SIEGEL & WALMSLEY LLC | 08/08/2024 | 127,724 | $420,000 | 100.00% | 0.50% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 120,574 | $395,000 | -22.90% | 0.47% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/21/2024 | 110,000 | $361,900 | 100.00% | 0.43% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 106,500 | $350,385 | 63.77% | 0.41% |
| STATE STREET CORP | 08/14/2024 | 81,403 | $267,816 | 0.00% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 74,491 | $245,076 | 0.00% | 0.29% |
| NORTHERN TRUST CORP | 08/14/2024 | 59,849 | $196,903 | -2.10% | 0.23% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 57,503 | $189,185 | -51.62% | 0.22% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 50,917 | $167,516 | -47.44% | 0.20% |
| SQUAREPOINT OPS LLC | 08/14/2024 | 41,255 | $135,729 | -15.97% | 0.16% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 34,847 | $114,647 | -11.32% | 0.14% |
| BLAIR WILLIAM & CO/IL | 08/12/2024 | 34,500 | $113,505 | -6.70% | 0.13% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 08/12/2024 | 27,252 | $89,659 | -65.33% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 26,700 | $87,843 | 10.33% | 0.10% |
| CHICAGO TRUST CO NA | 07/11/2024 | 16,700 | $54,943 | 0.00% | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 16,485 | $54,236 | -48.14% | 0.06% |
| CITADEL ADVISORS LLC | 08/14/2024 | 14,300 | $47,047 | -49.82% | 0.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 13,239 | $43,556 | 0.00% | 0.05% |
| XTX TOPCO LTD | 08/12/2024 | 11,739 | $38,621 | -16.76% | 0.05% |
| QUANTUM PRIVATE WEALTH, LLC | 07/17/2024 | 11,500 | $37,835 | 0.00% | 0.04% |
| UBS GROUP AG | 08/14/2024 | 11,018 | $36,249 | 462.14% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 10,564 | $34,755 | 0.00% | 0.04% |
| RAYMOND JAMES & ASSOCIATES | 07/19/2024 | 10,250 | $33,723 | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 3,638 | $11,969 | -52.09% | 0.01% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 1,200 | $3,948 | 100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1,000 | $3,290 | 100.00% | 0.00% |
| PLANTE MORAN FINANCIAL ADVISORS, LLC | 08/12/2024 | 1,000 | $3,290 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2024 | 747 | $2,000 | -2.35% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 350 | $1,152 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 300 | $987 | 100.00% | 0.00% |
| MORGAN STANLEY | 08/14/2024 | 192 | $632 | 405.26% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 183 | $602 | 100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 32 | $105 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 4 | $14 | -99.99% | 0.00% |
| LINDBROOK CAPITAL, LLC | 07/31/2024 | 4 | $13 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Eton Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ETON shares?
During the previous two years, 52 institutional investors and hedge funds held shares of Eton Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Opaleye Management Inc.: 2.4 M
VANGUARD GROUP INC: 1.03 M
Nantahala Capital Management, LLC: 940,733
Westside Investment Management, Inc.: 585,400
Acuitas Investments, LLC: 579,960
PARADIGM CAPITAL MANAGEMENT INC/NY: 300,000
-
What percentage of Eton Pharmaceuticals, Inc. stock is owned by institutional investors?
31.94% of Eton Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ETON ?
Institutional investors have bought a total of 8.24 M shares in the last 24 months. This purchase volume represents approximately $49.27 M in transactions.